GLP-1s have exploded in popularity after users discovered one of the side effects was dramatic weight loss. This has sent both pharmacies and financial markets into a frenzy over what impact this potential wonder drug will have.

August was a busy month for Australian investors with the majority of ASX-listed companies reporting. Here we provide an overview of two current portfolio holdings CBA and Coles.

August was a busy month for Australian investors with the majority of ASX-listed companies reporting FY23 results. Here we review the results and key investor takeaways of current portfolio holdings BHP and James Hardie.

Lawrance Private Wealth adviser Brigitta Hembrow-Gersey was a keynote panel speaker at the Financially Fearless - Empowering Women's Wealth event ran by Canberra Women in Business on 14 July 2023.

Andrew Doherty of AssureInvest provides an update on how stress on the banking sector is affecting the investment outlook.

If there is one word to describe the calendar year 2022, it would be volatile.

Markets largely moved in response to two macro variables: inflation and interest rates. It became clear early in the year that inflation was not in fact, transitory. Record-low employment, populations eager to spend after two years of intermittent lockdowns and pandemic-induced labour and shipping constraints created a perfect storm where demand exceeded supply. The Russia-Ukraine war only exacerbated these factors.